Revvity for Diagnostics

553 posts

Revvity for Diagnostics banner
Revvity for Diagnostics

Revvity for Diagnostics

@RevvityDX

Expanding the boundaries of human potential through science. Learn more at https://t.co/AHnnVr9zyf

Beigetreten Nisan 2023
2 Folgt69 Follower
Revvity for Diagnostics
Revvity for Diagnostics@RevvityDX·
RNA-seq experiments often waste resources on uninformative molecules. CRISPR-based DASH offers a smarter solution, high specificity, easy integration, and compatibility with samples. Sign up here: ms.spr.ly/6015QnR9B For research use only. Not for use in diagnostic procedures
English
0
0
0
14
Revvity for Diagnostics
Revvity for Diagnostics@RevvityDX·
A new study in Genome Medicine reveals a game-changing capability: detecting both genetic variants and methylation patterns in a single PacBio long-read sequencing run. ms.spr.ly/6014QiQP2
English
0
0
0
191
Revvity for Diagnostics
Revvity for Diagnostics@RevvityDX·
Liquid biopsy is transforming cancer research — with a simple blood draw to analyze ctDNA. Our latest article in Pathology in Practice explores how advanced cfDNA extraction tech is making large-scale liquid biopsy research more powerful and accessible: ms.spr.ly/6010Qg6KI
English
0
0
0
9
Revvity for Diagnostics
Revvity for Diagnostics@RevvityDX·
Are you tired of uninformative molecules cluttering your RNA-seq data? Join our webinar “CRISPR-based RNA depletion for challenging applications” RSVP here: ms.spr.ly/6012Qnu0O #RNAseq For research use only. Not for use in diagnostic procedures
English
0
0
0
27
Revvity for Diagnostics
Revvity for Diagnostics@RevvityDX·
Curious about how to classify variants showing biological impact but limited clinical relevance? Visit Christin Collins’ poster at #ACMGMtg26 ms.spr.ly/6013QexBL Join us and dive deeper into this critical challenge!
English
0
0
0
20
Revvity for Diagnostics
Revvity for Diagnostics@RevvityDX·
At #ACMGMtg26? Don’t miss Naga Guruju’s presentation exploring duplications in Duchenne and Becker muscular dystrophy. ms.spr.ly/6016Qeawm Stop by to hear key insights and connect with our experts to dive deeper into the data!
English
0
0
0
29